Axonics Modulation Technologies Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Axonics Modulation are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Axonics Modulation Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Axonics Modulation is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 238.8 M | |
| Free Cash Flow | -5.6 M |
Axonics |
Axonics Modulation Relative Risk vs. Return Landscape
If you would invest (100.00) in Axonics Modulation Technologies on December 27, 2024 and sell it today you would earn a total of 100.00 from holding Axonics Modulation Technologies or generate -100.0% return on investment over 90 days. Axonics Modulation Technologies is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Axonics, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Axonics Modulation Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Axonics Modulation's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Axonics Modulation Technologies, and traders can use it to determine the average amount a Axonics Modulation's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AXNX |
Based on monthly moving average Axonics Modulation is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Axonics Modulation by adding Axonics Modulation to a well-diversified portfolio.
Axonics Modulation Fundamentals Growth
Axonics Stock prices reflect investors' perceptions of the future prospects and financial health of Axonics Modulation, and Axonics Modulation fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Axonics Stock performance.
| Return On Equity | -0.0089 | |||
| Return On Asset | -0.0063 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 3.32 B | |||
| Shares Outstanding | 51.11 M | |||
| Price To Earning | (10.68) X | |||
| Price To Book | 5.46 X | |||
| Price To Sales | 8.40 X | |||
| Revenue | 366.38 M | |||
| EBITDA | 7.78 M | |||
| Cash And Equivalents | 213.23 M | |||
| Cash Per Share | 4.53 X | |||
| Total Debt | 27.62 M | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 13.00 X | |||
| Cash Flow From Operations | (2.02 M) | |||
| Earnings Per Share | (0.10) X | |||
| Total Asset | 719.92 M | |||
| Retained Earnings | (380.35 M) | |||
| Current Asset | 171.14 M | |||
| Current Liabilities | 12.98 M | |||
Things to note about Axonics Modulation performance evaluation
Checking the ongoing alerts about Axonics Modulation for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Axonics Modulation help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Axonics Modulation is not yet fully synchronised with the market data | |
| Axonics Modulation has some characteristics of a very speculative penny stock | |
| Axonics Modulation has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 366.38 M. Net Loss for the year was (6.09 M) with profit before overhead, payroll, taxes, and interest of 197.66 M. | |
| Axonics Modulation Technologies currently holds about 213.23 M in cash with (2.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.53. | |
| Over 87.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Axonics Modulation's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Axonics Modulation's stock is overvalued or undervalued compared to its peers.
- Examining Axonics Modulation's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Axonics Modulation's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Axonics Modulation's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Axonics Modulation's stock. These opinions can provide insight into Axonics Modulation's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Axonics Stock
If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |